Top Tweets for #MRDTesting
"92% of #oncologists report that if their patients knew about #MRDtesting as an option, they would be interested in incorporating it into their #cancer management and monitoring plans," reports Yuri Fesko, MD, Senior Vice President and Chief Medical Officer for Quest Diagnostics.
🚀 The Global Minimal Residual Disease (MRD) Testing Market is projected to grow at an impressive 11% CAGR from 2026 to 2031
📥 https://t.co/rZARWcoIgN
#MRDTesting #CancerDiagnostics #MolecularDiagnostics #NGS #PCR #Oncology #LiquidBiopsy #ClinicalTrials
Myeloma experts @jmikhaelmd and @Bethfaiman discuss how proposed cure definitions are already changing myeloma care, including increased MRD testing to monitor depth of remission after treatment ends.
#MRD #MRDtesting #AsktheIMF
What are the differences between Molecular circulating tumor DNA (ctDNA) testing and minimal residual disease (MRD) testing?
Now presenting Dr. @Joshua_Reuss!
#LungCancer #TargetedTherapies #TrueOrFalse #Molecularprofiling #MRDTesting #ctDNATesting
@CharlesSwanton On the need for better cancer testing:
"As medical advances improve longevity, more pts than ever face the looming risk of cancer recurrence – and the anxieties & challenges that go with it,” —Yuri A. Fesko, CMO @QuestDX
https://t.co/h8ik0AvIn3 via @AgeTechWorld
#MRDtesting
Clinical evidence via $PSNL's collab w TRACERx consortium—TRAcking Cancer Evolution thru therapy Rx
Study: Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction https://t.co/WOUSHRuRaf (OA)
#ctDNA #MRD #MRDtesting
#CancerTesting #Oncology
🎉 MAJOR NEWS: Medicare now covers NeXT Personal® MRD testing for #LungCancer surveillance!
✅ Coverage applies for surveillance of stage I-III #NSCLC patients.
✅ Coverage determination backed by groundbreaking TRACERx data (published in Cell).
✅ NeXT Personal detects residual disease with high accuracy.
With 230K new lung cancer cases annually and the risk of recurrence a top concern, this coverage gives patients and doctors a powerful tool to navigate uncertainty in their cancer journey. 💪
Learn more: https://t.co/WBC6wQ80Tl.
#Medicare #MRD #PrecisionOncology
Minimal Residual Disease Testing Market to $6.27 Bn by 2034 | 12.4% CAGR Key Players: F. Hoffmann-La Roche, Adaptive Biotechnologies, Natera, Illumina
To Know More ; https://t.co/dGUynEvN1k
#mrdtesting #precisiononcology #cancerdiagnostics #hematology #personalizedmedicine
🚀 100K patients and counting! Patients and providers continue to trust clonoSEQ as the proven standard for #MRDtesting in #BloodCancer care.
See why: https://t.co/248Wbewe3r
clonoSEQ is FDA-cleared to assess MRD in CLL, MM and ALL. For further info: https://t.co/sE39cv05vb
Morphologic remission ≠ cure.
Many centers still rely on diagnostic panels not designed for MRD. Don’t settle for suboptimal sensitivity. Talk with our MRD Experts⟶
https://t.co/MPxz54qlT4
#MRDtesting #AMLtransplant #BMTcenters #FlowCytometry #NGS #LabPMM
We’ll be at #ASH25! Stop by booth 1701 to connect with us and learn more about #clonoSEQ: the proven standard in heme #MRDtesting.
clonoSEQ is FDA-cleared to assess MRD in CLL, MM and ALL. For further info: https://t.co/sE39cuZxFD
clonoSEQ #MRDtesting allows for highly sensitive, tumor-informed assessment of disease burden in MCL, so you can manage patients with confidence. Learn more https://t.co/2wUwxAg7ar
clonoSEQ is FDA-cleared to assess MRD in CLL, MM and ALL. For further info: https://t.co/sE39cuZxFD
From detection to decision-making: clonoSEQ #MRDtesting supports precision care across multiple blood cancers. Stop by Booth 235 at #JADPROLive to learn more.
clonoSEQ is FDA-cleared to assess MRD in CLL, MM and ALL. For further info: https://t.co/sE39cuZxFD
According to Levis et al. (Blood, 2025), MRD positivity after induction or before HCT is the strongest predictor of relapse. Learn more about LabPMM’s fast, sensitive MRD assays. https://t.co/jueHWEQI4t
#AML #MRDtesting #TransplantOutcomes #LeukemiaResearch #LabPMM
clonoSEQ #MRDtesting provides you and your family with the confidence that you are monitoring ALL as vigilantly as you manage treatment.
Learn more: https://t.co/QlMQSeRs20
clonoSEQ is FDA-cleared to assess MRD in CLL, MM and ALL. For further info: https://t.co/sE39cuZxFD
Medical research is key to innovation, and medical innovation saves lives! I am so excited for the latest innovation by @ExactSciences! #Oncodetect #MRDTesting
MRD testing is one of the fastest-growing areas in oncology. By detecting signs of cancer recurrence earlier than traditional methods, innovations like the Oncodetect® test add a powerful molecular layer of insight. Read more: https://t.co/HMWjvnOwmJ @statnews
Ultrasensitive ctDNA detection means fewer false negatives and earlier insights. Haystack MRD™ delivers confidence in detecting even the smallest traces of residual disease. More at https://t.co/GZqNkh8KVS
#ctDNA #MRDTesting #Oncology
Confident treatment choices require sensitive tools. Haystack MRD™ is designed to detect even the smallest traces of ctDNA in a blood sample, for earlier insights. Learn more at https://t.co/nlBn8JAkIA
#MRDTesting #CancerCare
Want to know more about #MRDtesting? Explore @HealthTree’s MRD Guide—a free, multimedia resource for patients with #MultipleMyeloma.
👉 Start here: https://t.co/25rzyCYD6r
#BloodCancerAwarenessMonth
🎥 MRD in a Minute: Signatera™ Genome
At #ASCO 2025, @NateraGenetics President Solomon Moshkevich explains how Signatera Genome makes #MRD testing clearer for physicians & builds confidence for patients.
🎬 Hear the insights: https://t.co/ft5vYlBASO
#Oncology #MRDTesting
The future of cancer recurrence monitoring is here. Haystack MRD™ enables real-time assessment of therapy effectiveness through ctDNA kinetics. Learn more at https://t.co/uTPyNkK7S0
#OncologyInnovation #MRDTesting
Last Seen Hashtags on Sotwe
EcuadorSexual
Seen from Brazil
ห้องน้ำรูสอด
Seen from Thailand
ebonyincest
Seen from United States
女主女贝
Seen from United States
rapebait
Seen from Guatemala
fridaynightfunkinnsfw #fnfnsfw
Seen from Germany
違法入国外国人即刻自国へ強制送還
Seen from United Kingdom
ไซด์ไลน์โคราช
Seen from Thailand
Acquafina
Seen from United States
tranny
Seen from Turkey
Most Popular Users
Elon Musk 
@elonmusk
240.1M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
108.8M followers
Narendra Modi
@narendramodi
106.9M followers
Rihanna
@rihanna
97.2M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.5M followers
KATY PERRY
@katyperry
86.7M followers
Taylor Swift
@taylorswift13
80.5M followers
Lady Gaga
@ladygaga
72.1M followers
Kim Kardashian
@kimkardashian
69.3M followers
YouTube
@youtube
68.6M followers
Virat Kohli
@imvkohli
68.4M followers
Bill Gates
@billgates
63.4M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
60.9M followers
X
@x
60.9M followers
CNN Breaking News
@cnnbrk
59.9M followers